Spred1 antibody

GeneTex

Spred1 antibody

9

This Spred1 antibody is predicted to have no cross-reactivity to Spred2 or Spred3.

WB: 1 - 2 microg/mL. IHC-P: 2.5 microg/mL. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.

Western Blot, ELISA, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin

Research Use Only

Polyclonal

1 mg/ml

Unconjugated

Liquid

SPRED1

sprouty related EVH1 domain containing 1

hSpred1; LGSS; NFLS; PPP1R147; protein phosphatase 1, regulatory subunit 147; spred-1; sprouty-related, EVH1 domain-containing protein 1; suppressor of Ras/MAPK activation

Rabbit

IgG

Sprouty-related, EVH1 domain-containing protein 1

The Ras-MAP kinase pathway is essential for the differentiation of neuronal cells and myocytes; it is inhibited by Spred1, a member of the Sprouty family of proteins. Spred1 acts by suppressing the phosphorylation and activation of Raf. The Spred proteins have also been implicated in the negative feedback regulation of FGF signaling in embryogenesis and angiogenesis. Further studies have shown that expression levels of Spred1 and Spred2 proteins are inversely correlated with the incidence of tumor invasion and metastasis in human hepatocellular carcinoma (HHC), suggesting that these proteins could be useful as prognostic factors and therapeutic targets in HCC. Defects in this gene are a cause of neurofibromatosis type 1-like syndrome (NFLS). This Spred1 antibody is predicted to have no cross-reactivity to Spred2 or Spred3.

Human, Mouse, Rat

-20°C or -80°C,2°C to 8°C

12352203